Biotech Lock-Up Expiration Hell Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (814)	1/27/2004 12:47:28 PM
From: tuck	Read Replies (2) of 1005

POZN hasn't even announced any actual data, but the stock is up smartly on a tough day . . . >>CHAPEL HILL, N.C.--(BUSINESS WIRE)--Jan. 27, 2004--POZEN Inc. (Nasdaq:POZN - News) announced today that it will host a webcast on Wednesday, January 28, 2004 at 8:30 a.m. Eastern Time to discuss the results of a two-year rat carcinogenicity study for MT 100. A news release about the results of the study will be issued the same morning prior to the webcast. The webcast will be live and available for replay on POZEN's website at www.pozen.com. MT 100 is being developed as an oral first-line therapy for the treatment of migraine. << snip Makes one wonder if one of the rats talked to an Avalon analyst who sneaked into their cage in a rat costume: "I'm still here, there are no lumps, and I feel great." Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next